Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis-Reference-Cited by-同舟云学术

Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis

Published:2020-10 Issue: Volume:84 Page:102875
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Bartholomew Tyler S.,Tookes Hansel E.,Serota David P.,Behrends Czarina N.,Forrest David W.,Feaster Daniel J.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference68 articles.

1. Robustness to nonnormality of the Durbin-Watson test for autocorrelation;Ali;Journal of Econometrics,1993

2. Correlates of transactional sex among a rural population of people who inject drugs;Allen;AIDS and Behavior,2020

3. Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs—massachusetts, 2015–2018;Alpren;American Journal of Public Health,2020

4. Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis;Aspinall;Clinical Infectious Diseases,2013

5. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: A systematic review and meta-analysis;Aspinall;International Journal of Epidemiology,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Who declines “opt-out” HIV/HCV testing? Experience of an internal medicine resident continuity clinic serving a predominantly Black adult population in South Carolina.;Journal of the National Medical Association;2024-08

2. Impact of the COVID-19 Pandemic on HIV Test Uptake Among People Who Inject Drugs in the Context of an HIV Outbreak;AIDS and Behavior;2024-04-22

3. Trends in HIV-Related Services Offered by Substance Abuse Treatment Facilities;Cureus;2024-04-01

4. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services;Addiction Science & Clinical Practice;2024-03-25

5. CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers;Journal of Virus Eradication;2023-09